Literature DB >> 23000541

Structure and catalytic function of sphingosine kinases: analysis by site-directed mutagenesis and enzyme kinetics.

Daniel L Baker1, Truc Chi T Pham, Melanie A Sparks.   

Abstract

Sphingosine kinases 1 and 2 (SK1 and SK2) generate the bioactive lipid mediator sphingosine 1-phosphate and as such play a significant role in cell fate and in human health and disease. Despite significant interest in and examination of the role played by SK enzymes in disease, comparatively little is currently known about the three-dimensional structure and catalytic mechanisms of these enzymes. To date, limited numbers of studies have used site directed mutagenesis and activity determinations to examine the roles of individual SK residues in substrate, calmodulin, and membrane binding, as well as activation via phosphorylation. Assays are currently available that allow for both single and bisubstrate kinetic analysis of mutant proteins that show normal, lowered and enhanced activity as compared to wild type controls. Additional studies will be required to build on this foundation to completely understand SK mediated substrate binding and phosphoryl group transfer. A deeper understanding of the SK catalytic mechanism, as well as SK interactions with potential small molecule inhibitors will be invaluable to the future design and identification of SK activity modulators as research tools and potential therapeutics. This article is part of a Special Issue entitled Advances in Lysophospholipid Research.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000541     DOI: 10.1016/j.bbalip.2012.09.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors.

Authors:  Yugesh Kharel; Sayeh Agah; Tao Huang; Anna J Mendelson; Oluwafunmilayo T Eletu; Peter Barkey-Bircann; James Gesualdi; Jeffrey S Smith; Webster L Santos; Kevin R Lynch
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

3.  HJURP Promotes Epithelial-to-Mesenchymal Transition via Upregulating SPHK1 in Hepatocellular Carcinoma.

Authors:  Tianchi Chen; Lingfeng Zhou; Yuan Zhou; Wuhua Zhou; Hechen Huang; Shengyong Yin; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Int J Biol Sci       Date:  2019-05-07       Impact factor: 6.580

4.  Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.

Authors:  Heba Alshaker; Shyam Srivats; Danielle Monteil; Qi Wang; Caroline M R Low; Dmitri Pchejetski
Journal:  Breast Cancer Res Treat       Date:  2018-07-24       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.